Season 2

How the Indestructible Molecule that is PFAS Effects the Environment

In the most recent episode of “There’s More to IT,” host Jason Claybrook discussed the widespread exposure of Per and Polyfluoroalkyl Substances, better known as PFAS, in various aspects of everyday life. His guest was Yuran Li, the director of MS Commercial Strategies at Alternative Biomedical Solutions — a Texas based laboratory. The two talked…

Read More

Latest

Season 2
Mastering the Science Behind Creating an IT Department

In this episode of There’s More to IT, host, Jason Claybrook, sat down with David McLaughlin, President & CEO, Columbia Advisory Group. The two discuss McLaughlin’s journey in the field, the importance of the advisory component in CAG’s work, and CAG’s role in higher education. McLaughlin co-founded Columbia Advisory Group a little over 10…

Read More
Food & Beverage
Is Holistic Nutrition the Answer for Improving Overall Nutritional Needs?

In the latest episode of the podcast “There’s More to IT,” host Jason Claybrook brings on his wife Niki, and diverges from technology to discuss maintaining healthy-eating habits, as more and more people return to work traveling as pandemic restrictions ease. As a holistic nutrition consultant based in Texas, Claybrook consults clients that have…

Read More
Season 2
Technology Leaders Are No Longer Behind the Scenes, They Are Integral for Driving Strategy

Toby Buckalew, Interim CIO, Columbia Advisory Group, is a leading technology strategist with over thirty years of industry experience. Jason Claybrook sat down with Buckalew for an in-depth discussion on his career and insights into the current state of IT management. Buckalew witnessed plenty of technology evolution and innovation during his lengthy career in…

Read More
Sciences
The Industry That is Depending on Science and Regulation to Grow

Yuran Li, Director, MS Commercial Strategies, Alternative Biomedical Solutions (ABS), is a biochemist by training. Still, his fascinations with physics, math, and probability have led him down some interesting paths, including some stints in the professional poker world. Lucky for ABS, he chose the science route. Cannabis is a schedule 1 drug classification by the…

Read More

Latest

weekly drive-in
Metropolis: Weekly Drive-in
April 15, 2026

Metropolis “Weekly Drive In” reflects a new era of storytelling where AI meets real-world execution, turning everyday field performance into momentum. Centered on genuine conversions and local wins, the series highlights how the company is scaling not just through technology, but through visibility and shared recognition. In an emerging recognition economy, these updates act…

Read More
Drive In, Drive Out: The Rhythm of Metropolis
April 15, 2026

Behind the seemingly mundane choreography of a drive-in lies a broader story about how modern cities script behavior, turning even the simplest actions into rehearsed routines. What looks like repetition is really a quiet testament to systems designed for flow and control, where efficiency often outweighs individuality. In places like Metropolis, the rhythm of…

Read More
telemetry
Visibility at Scale: How Data, Telemetry, and IT Architecture Enable High-Performance Data Centers
April 14, 2026

As AI infrastructure scales at an unprecedented pace, the complexity of managing data center operations has shifted from purely physical challenges to deeply digital ones. Today’s facilities generate enormous volumes of telemetry, and industry estimates suggest hyperscale and AI data centers produce millions of data points per second. At that scale, visibility is no…

Read More
healthcare
The Early-Stage Playbook for Healthcare Founders: Credibility, Founder Mindset, and Real Market Fit
April 13, 2026

Healthcare innovation is having a moment. With over 500 startups applying annually to leading accelerators like Health Wildcatters, the sector is seeing a surge of founders eager to tackle inefficiencies in care delivery, diagnostics, and patient experience. At the same time, digital health is regaining momentum—after a period of market correction, funding went up…

Read More